Sun Pharma board to consider up to ₹15,000 crore NCD issue
Sun Pharmaceutical Industries said its board will meet Oct. 12 to consider issuing listed, rated, unsecured and redeemable non-convertible debentures worth up to ₹15,000 crore.
Sun Pharmaceutical Industries said its board will meet Oct. 12 to consider issuing listed, rated, unsecured and redeemable non-convertible debentures worth up to ₹15,000 crore.